Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bausch & Lomb

This article was originally published in The Gray Sheet

Executive Summary

Acquires Miami-based Hansa Research & Development, Inc., the maker of the Hansatome and Automatic Corneal Shaper microkeratomes "used in the majority of refractive surgery procedures worldwide for vision correction," B&L says Jan. 7. The firm purchased Hansa from Johann, Imra and Brigitta Hellenkamp, who will continue to work as consultants for B&L Surgical. All assets used in connection with the Hansatome microkeratome business are included in the sale. Terms of the deal were not disclosed

You may also be interested in...



Bausch & Lomb Sues Moria For Microkeratome Patent Infringement

Bausch & Lomb is seeking to defend its position in the increasingly competitive laser eye surgery market through a patent infringement suit filed Aug. 23 in a Philadelphia federal court against Moria S.A. and its U.S. distributor Microtech.

Entries Begin To Roll In For 2024 Industry Awards

Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel